Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1

Transplantation

Volumn 74, Issue 5, 2002, Pages 591-598

  Tullius, Stefan G ^a   Nieminen Kelhä, Melina ^a   Buelow, Roland ^a   Reutzel Selke, Anja ^a   Martins, Paulo N ^a   Pratschke, Johann ^a   Bachmann, Ulrike ^a   Lehmann, Manfred ^a   Southard, Daniel ^a   Iyer, Suhasani ^a   Schmidbauer, Georg ^a   Sawitzki, Birgit ^a   Reinke, Petra ^a   Neuhaus, Peter ^a   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; COBALT DERIVATIVE; CYTOKINE; GAMMA INTERFERON; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; PROTEIN BCL X; PROTOPORPHYRIN; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INDUCTION; GRAFT FAILURE; ISCHEMIA; KIDNEY TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; REPERFUSION INJURY; T LYMPHOCYTE;

EID: 0037106492     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200209150-00001     Document Type: Article

References (35)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
2. Tullius SG, Tilney NL. Both Alloantigen-dependent and independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313.
3. Tullius SG, Reutzel-Selke A, Egermann F, et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J Am Soc Nephrol 2000; 11: 1317.
4. Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54: 972.
5. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidneys from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
6. The US Scientific Registry of Transplant Recipients and The Organ Procurement and Transplantation Network. 1999 annual report. Richmond, VA, United Network for Organ Sharing 1999.
7. Chertow G, Brenner BM, Mackenzie HS, et al. Non-immunologic predictors of chronic renal allograft failure: data from the United Network of Organ sharing. Kidney Int (suppl) 1995; 52: 48.
8. Maines, MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517.
9. Platt JL, Nath KA. Heme oxygenase: protective gene or Trojan horse. Nat Med 1998; 4: 1364.
10. Woo J, Iyer S, Cornejo MC, et al. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression ofhaem oxygenase (HSP 32). Transplant Immunol 1998; 6: 84.
11. Cuturi MC, Christoph F, Woo J, et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol Med 1999; 5: 820.
12. Squiers E, Christoph F, Woo J, et al. Induction ofheme oxygenase by CoPP in small bowel donors results in decrease of preservation/reperfusion injury and improved isograft survival. Transplantation (suppl) 1999; 67: 652.
13. Soares MP, Lin Y, Anrather J, et al: Expression of HO-1 can determine cardiac xenograft survival. Nat Med 1998; 4: 1073.
14. DeBruyne LA, Magee JC, Buelow R, et al. Gene transfer ofimmunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival. Transplantation 2000; 69: 120.
15. Hancock WW, Buelow R, Sayegh MH, et al. Antibody induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392.
16. Diamond JR, Tilney NL, Frye J, et al. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992; 52: 710.
17. Amersi F, Buelow R, Kato H, et al. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 1999; 104: 1631.
18. Panahian N, Yoshiura M, Maines, D. Overexpression ofheme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 1999; 77: 1187.
19. Vogt BA, Shanley TP, Croatt A, et al. Glomerular inflammation induces resistance to tubular injury in the rat. J Clin Invest 1996; 9: 2139.
20. Laniado-Schwartzman M, Abraham NG, Conners M, et al. Hemoxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol 1997; 53: 1069.
21. Willis D, Moore AR, Frederick R, et al. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 1996; 2: 87.
22. Otterbein L, Sylvester SL, Choi AM. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 1995; 13: 387.
23. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1 deficient cells. Proc Natl Acad Sci U S A. 1997; 94: 10925.
24. Yachie A, Niida Y, Wada T, et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Inves 1999; 103: 129.
25. Nakagami T, Toyomura K, Kinoshita T, et al. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1993; 1158: 189.
26. Pratt JR, Hibbs MJ, Laver AJ, et al. Allograft immune response with sCR1 intervention. Transplant Immunol 1996; 4: 72.
27. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043.
28. Haga Y, Tempero MA, Kay D, et al. Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutinin-induced proliferation and interleukin-2 production of human lymphocytes. Dig Dis Sci 1996; 41: 1468.
29. Haga Y, Tempero MA, Zetterman RK. Unconjugated bilirubin inhibits in vitro major histocompatibility complex-unrestricted cytotoxicity of human lymphocytes. Biochim Biophys Acta 1996; 1316: 29.
30. Verma A, Hirsch DJ, Glatt CE, et al. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381.
31. Brune B, Ulrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32: 497.
32. Arias-Diaz JA, Vara E, Garcia C, et al. Evidence for a cyclic guanosine monophosphate-dependent, carbon monoxide-mediated, signaling system in the regulation of TNF-alpha production by human pulmonary macrophages. Arch Surg 1995; 130: 1287.
33. Finn JT, Grunwald ME, Yau KW. Cyclic nucleotide-gated ion channels: an extended family with diverse functions. Annu Rev Physiol 1996; 58: 395.
34. Brouard S, Otterbein LE, Anrather J, et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015.
35. Kutty RK, Maines MD. Purification and characterization of biliverdin reductase from rat liver. J Biol Chem 1981; 256: 3956.